Ident. | Authors (with country if any) | Title |
---|
000094 (2017) |
Nadhir Litim [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Effects of progesterone administered after MPTP on dopaminergic neurons of male mice. |
000243 (2016) |
Edith Miville-Godbout [Canada] ; Mélanie Bourque [Canada] ; Marc Morissette [Canada] ; Sara Al-Sweidi [Canada] ; Tara Smith [Canada] ; Asuka Mochizuki [Canada, Japon] ; Vijitha Senanayake [Canada] ; Dushmanthi Jayasinghe [Canada] ; Li Wang [Canada] ; Dayan Goodenowe [Canada] ; Thérèse Di Paolo [Canada] | Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice |
000273 (2016) |
Mohammed Filali [Canada] ; Robert Lalonde [France] | Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP. |
000361 (2016) |
S. Al-Sweidi [Canada] ; M. Morissette [Canada] ; T. Di Paolo [Canada] | Estrogen receptors modulate striatal metabotropic receptor type 5 in intact and MPTP male mice model of Parkinson's disease. |
000424 (2016) |
Marc Morissette [Canada] ; Nicolas Morin [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada] | Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients. |
000610 (2015) |
Jihye Park [Corée du Sud] ; Chae-Seok Lim [Corée du Sud] ; Hyunhyo Seo [Corée du Sud] ; Chung-Ah Park [Corée du Sud] ; Min Zhuo [Canada] ; Bong-Kiun Kaang [Corée du Sud] ; Kyungmin Lee [Corée du Sud] | Pain perception in acute model mice of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) |
000877 (2014) |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Katie D. Lewis [Australie] ; James B. Koprich [Canada] ; M Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada] | UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset. |
000973 (2014) |
Nicolas Morin [Canada] ; Thérèse Di Paolo [Canada] | Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates |
000C92 (2013) |
Vincent A. Jourdain [Canada] ; Laurent Grégoire ; Marc Morissette ; Nicolas Morin ; Martin Parent ; Thérèse Di Paolo | Potentiation of response to low doses of levodopa in MPTP-injected monkeys by chemical unilateral subthalamotomy. |
001116 (2012) |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Michael N. Gandy [Australie] ; M. Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada] | The Monoamine Re-Uptake Inhibitor UWA-101 Improves Motor Fluctuations in the MPTP-Lesioned Common Marmoset |
001213 (2012) |
Isabelle St-Amour ; Mélanie Bousquet ; Isabelle Paré ; Janelle Drouin-Ouellet ; Francesca Cicchetti ; Renée Bazin ; Frédéric Calon | Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson’s disease |
001493 (2012) |
D. Domenger [Canada] ; D. Dea [Canada] ; L. Theroux [Canada] ; L. Moquin [Canada] ; A. Gratton [Canada] ; J. Poirier [Canada] | The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain |
001525 (2012) |
D. W. Luchtman [Canada] ; Q. Meng [Canada] ; C. Song [Canada, République populaire de Chine] | Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease |
001575 (2011) |
Janelle Drouin-Ouellet [Canada] ; Claire Gibrat [Canada] ; Mélanie Bousquet [Canada] ; Frédéric Calon [Canada] ; Jasna Kriz [Canada] ; Francesca Cicchetti [Canada] | The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration |
001778 (2011) |
James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada] | The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease |
001986 (2010) |
Susan H. Fox [Canada] ; Jonathan M. Brotchie | The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. |
001A02 (2010) |
Hamid Y. Qureshi [Canada] ; Hemant K. Paudel [Canada] | Parkinsonian Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and α-Synuclein Mutations Promote Tau Protein Phosphorylation at Ser262 and Destabilize Microtubule Cytoskeleton in Vitro* |
001A70 (2010) |
Hossein Aleyasin [Canada] ; Maxime W. C. Rousseaux [Canada] ; Paul C. Marcogliese [Canada] ; Sarah J. Hewitt [Canada] ; Isabella Irrcher [Canada] ; Alvin P. Joselin [Canada] ; Mohammad Parsanejad [Canada] ; Raymond H. Kim [Canada] ; Patrizia Rizzu [Pays-Bas] ; Steve M. Callaghan [Canada] ; Ruth S. Slack [Canada] ; Tak W. Mak [Canada] ; David S. Park [Canada, Corée du Sud] | DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway |
001C36 (2010) |
Tom H. Johnston [Canada] ; Anne Van Der Meij [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Effect of histamine H2 receptor antagonism on levodopa–induced dyskinesia in the MPTP‐macaque model of Parkinson's disease |
001C61 (2010) |
Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Daniel Lévesque [Canada] ; Thérèse Di Paolo [Canada] | BDNF levels are not related with levodopa‐induced dyskinesias in MPTP monkeys |
001C80 (2010) |
Marc Morissette [Canada] ; Pershia Samadi [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Nancy Belanger [Canada] ; Thérèse Di Paolo [Canada] | Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys |